Antibiotic Therapy for Neonatal Sepsis in the NICU

First-Line Antibiotic Regimens

The first-line antibiotic regimen for neonatal sepsis in the NICU is a combination of ampicillin and gentamicin, which targets the most common pathogens while minimizing the risk of developing antimicrobial resistance and adverse outcomes 1
The World Health Organization (WHO) recommends the combination of ampicillin and gentamicin as the first-line treatment for neonatal sepsis 1
Ampicillin covers Group B Streptococcus (GBS) and other gram-positive organisms, while gentamicin provides coverage for gram-negative bacteria, particularly Enterobacterales 1
The first-line regimen includes ampicillin at 50 mg/kg IV every 6 hours and gentamicin with dosing based on weight and gestational age (typically 4-5 mg/kg IV every 24-48 hours) 1
Alternative first-line options include benzylpenicillin + gentamicin and amoxicillin + gentamicin 1

Second-line options include amikacin + cloxacillin, cefotaxime (as alternative to aminoglycoside), and vancomycin (for suspected coagulase-negative staphylococci) 1
If gram-negative sepsis is suspected or confirmed, add cefotaxime or another antibiotic active against gram-negative bacteria 1

Culture-negative sepsis typically requires 7-10 days of treatment, while culture-positive sepsis requires 10-14 days 2
Re-evaluate at 48 hours and consider discontinuation if cultures are negative and clinical suspicion is low 2
Therapeutic drug monitoring is essential for gentamicin due to its narrow therapeutic index, including monitoring serum levels (peak and trough) and renal function 1

Prolonged empiric therapy beyond 48 hours without evidence of infection promotes antimicrobial resistance 2
Local antibiograms should guide empiric therapy decisions to ensure effective treatment and minimize resistance 2
Prompt initiation of antibiotics is critical in suspected sepsis to reduce mortality 2